tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AKLI Stock Latest News

Akili’s Acquisition by Virtual Therapeutics and Nasdaq Delisting
Company AnnouncementsAkili’s Acquisition by Virtual Therapeutics and Nasdaq Delisting
2y ago
8K
AKLI
Akili announces FDA authorization of EndeavorOTC
PremiumThe Fly
Akili announces FDA authorization of EndeavorOTC
2y ago
AKLI
Akili Announces Merger Agreement and Recommends Shareholder Approval
PremiumCompany Announcements
Akili Announces Merger Agreement and Recommends Shareholder Approval
2y ago
8K
AKLI
Akili to go private through merger agreement with Virtual Therapeutics
PremiumThe Fly
Akili to go private through merger agreement with Virtual Therapeutics
2y ago
AKLI
Akili to go private through merger agreement with Virtual Therapeutics
PremiumThe Fly
Akili to go private through merger agreement with Virtual Therapeutics
2y ago
AKLI
Akili reports Q1 net loss ($9.3M) vs. ($13.6M) last year
PremiumThe FlyAkili reports Q1 net loss ($9.3M) vs. ($13.6M) last year
2y ago
AKLI
Is AKLI a Buy, Before Earnings?
Premium
Pre-Earnings
Is AKLI a Buy, Before Earnings?
2y ago
AKLI
Akili partner in Japan submits SDT-001 for marketing approval
Premium
The Fly
Akili partner in Japan submits SDT-001 for marketing approval
2y ago
AKLI
Akili Enhances Board and Announces Financial Results
PremiumCompany Announcements
Akili Enhances Board and Announces Financial Results
2y ago
8K
AKLI
Akili sees cash, equivalents sufficient to fund operations into 2H25
PremiumThe Fly
Akili sees cash, equivalents sufficient to fund operations into 2H25
2y ago
AKLI
Akili reports Q3 revenue $702,000, consensus $22,000
PremiumThe Fly
Akili reports Q3 revenue $702,000, consensus $22,000
2y ago
AKLI
Akili participates in a conference call with LifeSci Capital
PremiumThe Fly
Akili participates in a conference call with LifeSci Capital
2y ago
AKLI
Akili CEO Eddie Martucci transitions to board chair, Matt Franklin to succeed
PremiumThe FlyAkili CEO Eddie Martucci transitions to board chair, Matt Franklin to succeed
2y ago
AKLI
Akili participates in a conference call with LifeSci Capital
Premium
The Fly
Akili participates in a conference call with LifeSci Capital
2y ago
AKLI
Akili participates in a conference call with LifeSci Capital
Premium
The Fly
Akili participates in a conference call with LifeSci Capital
2y ago
AKLI
Akili sees FY23 total operating expenses $55M-$60M
PremiumThe Fly
Akili sees FY23 total operating expenses $55M-$60M
2y ago
AKLI
Akili plans to transition to a non-prescription model, reduce headcount by 40%
PremiumThe Fly
Akili plans to transition to a non-prescription model, reduce headcount by 40%
2y ago
AKLI
Akili reports Q2 revenue $114,000, consensus $240,000
PremiumThe Fly
Akili reports Q2 revenue $114,000, consensus $240,000
3y ago
AKLI
Akili reports Q4 non-GAAP net loss ($19.54M) vs ($18.246M) last year
PremiumThe Fly
Akili reports Q4 non-GAAP net loss ($19.54M) vs ($18.246M) last year
3y ago
AKLI
Akili: EndeavorRx trial to treat ADHD in adolescents shows robust improvements
PremiumThe FlyAkili: EndeavorRx trial to treat ADHD in adolescents shows robust improvements
3y ago
AKLI
Akili initiated with an Equal Weight at Morgan Stanley
Premium
The Fly
Akili initiated with an Equal Weight at Morgan Stanley
3y ago
AKLI
Akili Interactive appoints Scott Kollins as chief medical officer
Premium
The Fly
Akili Interactive appoints Scott Kollins as chief medical officer
3y ago
AKLI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >